|
"po huang lee"的相關文件
顯示項目 946-955 / 1059 (共106頁)
<< < 90 91 92 93 94 95 96 97 98 99 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T03:23:22Z |
Liver transplantation in a patient with diffuse portal venous system thrombosis
|
Ho, M.-C. and Hu, R.-H. and Lai, H.-S. and Yang, P.-M. and Lai, M.-Y. and Lee, P.-H.; PO-HUANG LEE; MING-CHIH HO; REY-HENG HU; HONG-SHIEE LAI; PEI-MING YANG |
| 臺大學術典藏 |
2018-09-10T03:23:21Z |
Effectiveness of an organ-sharing program in providing zero HLA-A,B,DR mismatched kidneys for transplantation in Taiwan
|
Lee, P.-C. and Lee, P.-H. and Shaw, C.-K. and Lei, H.-Y. and Chen, J.-C. and Takemoto, S.; PO-HUANG LEE |
| 臺大學術典藏 |
2018-09-10T03:23:21Z |
Extracorporeal membrane oxygenation support of donor abdominal organs in non-heart-beating donors
|
Ko, W.-J. and Chen, Y.-S. and Tsai, P.-R. and Lee, P.-H.; PO-HUANG LEE |
| 臺大學術典藏 |
2018-09-10T03:23:21Z |
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
|
PO-HUANG LEE; Yu, M.-W. and Chang, H.-C. and Liaw, Y.-F. and Lin, S.-M. and Lee, S.-D. and Liu, C.-J. and Chen, P.-J. and Hsiao, T.-J. and Lee, P.-H. and Chen, C.-J. |
| 臺大學術典藏 |
2018-09-10T03:23:20Z |
An analysis of status of cadaver donors at The National Taiwan University Hospital: Eleven-year case review
|
PO-HUANG LEE; Ko, W.J. and Lin, M.H. and Lin, H.Y. and Tsao, C.I. and Lee, P.H. |
| 臺大學術典藏 |
2018-09-10T03:23:20Z |
Changes in health-related quality of life and working competence before and after liver transplantation
|
Shih, F.-J. and Hu, R.-H. and Ho, M.-C. and Lin, H.-Y. and Lin, M.-H. and Lee, P.-H.; 施富金;胡瑞恆;李伯皇; Shih, F.-J; Hu, R.-H; Ho, M.-C; Lin, H.-Y; Lin, M.-H; Lee, P.-H; PO-HUANG LEE; MING-CHIH HO; REY-HENG HU; Shih, F.-J; Hu, R.-H; Ho, M.-C; Lin, H.-Y; Lin, M.-H; Lee, P.-H |
| 臺大學術典藏 |
2018-09-10T03:23:20Z |
Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients
|
Hu, R.-H. and Lee, P.-H. and Tsai, M.-K.; PO-HUANG LEE; MENG-KUN TSAI; REY-HENG HU |
| 臺大學術典藏 |
2018-09-10T03:23:20Z |
Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients
|
PO-HUANG LEE; Chen, C.-N. and Cheng, Y.-M. and Liang, J.-T. and Lee, P.-H. and Hsieh, F.-J. and Yuan, R.-H. and Wang, S.-M. and Chang, M.-F. and Chang, K.-J. |
| 義守大學 |
2018-01 |
Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target
|
Ming-Shian Tsai;Po-Huang Lee;Cheuk-Kwan Sun;Ting-Chia Chiu;Yu-Chun Lin;I-Wei Chang;Po-Han Chen;Ying-Hsien Kao |
| 臺大學術典藏 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
PO-HUANG LEE; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Po-Huang Lee;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
顯示項目 946-955 / 1059 (共106頁)
<< < 90 91 92 93 94 95 96 97 98 99 > >>
每頁顯示[10|25|50]項目
|
